EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparing similarities and differences between NAFLD, MAFLD, and MASLD in the general U.S. population

Haoxuan Zou, Xiaopu Ma, Wen Pan, Yan Xie

Frontiers in Nutrition · 08.07.2024 · 11

DOI: 10.3389/fnut.2024.1411802 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 08.07.2024. Verfasst von Haoxuan Zou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recently, the multisociety Delphi consensus renamed non-alcoholic fatty liver disease (NAFLD) terminology [previously renamed metabolic-associated fatty liver disease (MAFLD)] as metabolic dysfunction-associated steatotic liver disease (MASLD). The aim of this study was to compare the similarities and differences between NAFLD, MAFLD, and MASLD and to clarify the impact of this new name change.

Methods

A cross-sectional study of 3,035 general subjects with valid vibration-controlled transient elastography data was conducted based on data from the National Health and Nutrition Examination Survey (NHANES) 2017–2020. NAFLD, MAFLD, and MASLD were defined according to the corresponding consensus criteria.

Results

Using controlled attenuation parameter (CAP) ≥274 dB/m and liver stiffness measurements (LSM) ≥9.7 kPa as the cutoff values for the presence of hepatic steatosis and advanced liver fibrosis (ALF), the prevalence of NAFLD, MAFLD, and MASLD were 38.01% (95% CI 35.78–40.29%), 41.09% (39.09–43.12%), and 37.9% (35.70–40.14%), respectively, and the corresponding prevalence of ALF was 10.21% (7.09–14.48%), 10.13% (7.06-14.35%), and 10.24% (7.11–14.53%), respectively. The kappa values for the three definitions were above 0.9. The prevalence and severity of the three definitions remained similar when the sensitivity analyses were performed using different CAP thresholds. The prevalence of NAFLD, MAFLD, MASLD, and ALF increased as the number of cardiometabolic risk factors (CMRF) increased.

Conclusions

Our findings highlight the consistency among the three definitions, especially between NAFLD and MASLD, so that the new consensus will not disturb the original NAFLD-related findings. Additionally, more attention should be paid to patients with a high number of CMRFs.

Schlagwörter

Stichwörter der Autor:innen

MAFLDMASLDNAFLDNHANESSLD

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Department of Health Management Center, The Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, Sichuan, China.

Zitieren

APA

Zou, H., Ma, X., Pan, W., & Xie, Y. (2024). Comparing similarities and differences between NAFLD, MAFLD, and MASLD in the general U.S. population. Frontiers in Nutrition, 11. https://doi.org/10.3389/fnut.2024.1411802

Vancouver

Zou H, Ma X, Pan W, Xie Y. Comparing similarities and differences between NAFLD, MAFLD, and MASLD in the general U.S. population. Frontiers in Nutrition. 2024;11. doi:10.3389/fnut.2024.1411802

BibTeX
@article{Zou2024,
  author = {Zou, Haoxuan and Ma, Xiaopu and Pan, Wen and Xie, Yan},
  title = {Comparing similarities and differences between NAFLD, MAFLD, and MASLD in the general U.S. population},
  journal = {Frontiers in Nutrition},
  year = {2024},
  volume = {11},
  doi = {10.3389/fnut.2024.1411802}
}
Kostenlos starten →